Brigham and Womens Faulkner Hospital is a licensed detox provider in Jamaica Plain, MA, listed in the SAMHSA treatment directory. Its team manages alcohol withdrawal, including the delirium tremens that can peak in the first two to four days. Benzodiazepine detox here is handled on a gradual, structured taper to prevent seizures rather than stopping abruptly. For opioid dependence it provides medically supervised detox, and it can pair that with medication to ease withdrawal. Buprenorphine (Suboxone) is offered to reduce opioid withdrawal and lower relapse and overdose risk. Detox is available on an outpatient basis, so clients can withdraw while living at home with scheduled visits. The facility reports accepting MassHealth. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 984-9911
and we will help you confirm openings, insurance, and next steps.
Detox services
Alcohol DetoxificationBenzodiazepines DetoxificationOpioids detoxificationMedication routinely used during detoxification
Level of care
Hospital inpatient/24-hour hospital inpatientOutpatientHospital inpatient detoxificationOutpatient detoxificationOutpatient day treatment or partial hospitalizationOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
MedicareMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than Medicaid
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState mental health departmentState department of healthHospital licensing authorityThe Joint Commission
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
170 Morton Street, Suite 4-South, Jamaica Plain, MA 02130
Alcohol DetoxificationBenzodiazepines DetoxificationCocaine DetoxificationFederal, or any government funding for substance use treatment programsMedicare